RECRUITINGOBSERVATIONAL

Unclassified GENotypes of Autoinflammatory Diseases and AA Amyloidosis

Physiopathological Investigation of Unclassified GENotypes of Autoinflammatory Diseases and AA Amyloidosis

About This Trial

Patients with autoinflammatory diseases (AID) have recurrent episodes of systemic inflammation accompanied by nonspecific elevation of blood inflammation markers typically absent between attacks. A complication of autoinflammatory diseases is AA amyloidosis, which can lead to renal failure and dialysis. Advances in genetic analysis have led to the identification of new autoinflammatory diseases and thus new pathophysiological pathways. However, genetic analyses are sometimes confronted with results that are difficult to interpret. These are the Variants of Unknown Significance, for which genetic analysis alone does not allow to determine if the genetic mutation is responsible for the symptoms. genetic analysis sometimes has limitations in the diagnosis of AID which can only be overcome by pathophysiological studies of the variants found.

Who May Be Eligible (Plain English)

Who May Qualify: Inclusion criteria for patients to be studied: - Patients over 18 years of age with the capacity to give express free and willing to sign a consent form and; - Minor patients under 18 years of age with both parents or legal guardians giving consent; - Patients with unclassified IAD or AA amyloidosis of undetermined etiology; - Patients followed in one of the study departments; - Patients weighing more than 15 kg. Inclusion criteria for control patients: - Patients over 18 years of age with the capacity to give free and informed express consent; - Patients with IAD classified with well-defined international criteria or ; - Patients who have undergone cosmetic surgery or blood donors). Who Should NOT Join This Trial: - Patients unable to give express free and willing to sign a consent form; - Subjects under guardianship, curatorship or safeguard of justice; - Subjects who do not speak French; - Subjects unable to answer questions or express themselves; - Patients weighing less than 15 kg; - Patients without social security coverage Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: Inclusion criteria for patients to be studied: * Patients over 18 years of age with the capacity to give express free and informed consent and; * Minor patients under 18 years of age with both parents or legal guardians giving consent; * Patients with unclassified IAD or AA amyloidosis of undetermined etiology; * Patients followed in one of the study departments; * Patients weighing more than 15 kg. Inclusion criteria for control patients: * Patients over 18 years of age with the capacity to give free and informed express consent; * Patients with IAD classified with well-defined international criteria or ; * Patients who have undergone cosmetic surgery or blood donors). Exclusion Criteria: * Patients unable to give express free and informed consent; * Subjects under guardianship, curatorship or safeguard of justice; * Subjects who do not speak French; * Subjects unable to answer questions or express themselves; * Patients weighing less than 15 kg; * Patients without social security coverage

Locations (1)

Service médecine interne-Hôpital Tenon

Paris, France